These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8305454)

  • 1. Bioadhesive, collagen-modified liposomes: molecular and cellular level studies on the kinetics of drug release and on binding to cell monolayers.
    Yerushalmi N; Margalit R
    Biochim Biophys Acta; 1994 Jan; 1189(1):13-20. PubMed ID: 8305454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and cellular studies of hyaluronic acid-modified liposomes as bioadhesive carriers for topical drug delivery in wound healing.
    Yerushalmi N; Arad A; Margalit R
    Arch Biochem Biophys; 1994 Sep; 313(2):267-73. PubMed ID: 8080272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid-modified bioadhesive liposomes as local drug depots: effects of cellular and fluid dynamics on liposome retention at target sites.
    Yerushalmi N; Margalit R
    Arch Biochem Biophys; 1998 Jan; 349(1):21-6. PubMed ID: 9439578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical evaluation of a stability-driven approach to drug entrapment in regular and in surface-modified liposomes.
    Peer D; Margalit R
    Arch Biochem Biophys; 2000 Nov; 383(2):185-90. PubMed ID: 11185552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronan-modified and regular multilamellar liposomes provide sub-cellular targeting to macrophages, without eliciting a pro-inflammatory response.
    Glucksam-Galnoy Y; Zor T; Margalit R
    J Control Release; 2012 Jun; 160(2):388-93. PubMed ID: 22019559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronan is a key component in cryoprotection and formulation of targeted unilamellar liposomes.
    Peer D; Florentin A; Margalit R
    Biochim Biophys Acta; 2003 May; 1612(1):76-82. PubMed ID: 12729932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase inhibition by diclofenac formulated in bioadhesive carriers.
    Elron-Gross I; Glucksam Y; Melikhov D; Margalit R
    Biochim Biophys Acta; 2008 Apr; 1778(4):931-6. PubMed ID: 18230331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposome-mediated drug targeting in topical and regional therapies.
    Margalit R
    Crit Rev Ther Drug Carrier Syst; 1995; 12(2-3):233-61. PubMed ID: 9501970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipsome-formulated enzymes for organophosphate scavenging: butyrylcholinesterase and Demeton-S.
    Fischer S; Arad A; Margalit R
    Arch Biochem Biophys; 2005 Feb; 434(1):108-15. PubMed ID: 15629114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism and kinetics of the loss of poorly soluble drugs from liposomal carriers studied by a novel flow field-flow fractionation-based drug release-/transfer-assay.
    Hinna AH; Hupfeld S; Kuntsche J; Bauer-Brandl A; Brandl M
    J Control Release; 2016 Jun; 232():228-37. PubMed ID: 27112112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of platelets with liposomes containing dodecapeptide sequence from fibrinogen.
    Nishiya T; Toma C
    Thromb Haemost; 2004 Jun; 91(6):1158-67. PubMed ID: 15175803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(vinyl methyl ether/maleic anhydride)-Doped PEG-PLA Nanoparticles for Oral Paclitaxel Delivery To Improve Bioadhesive Efficiency.
    Wang Q; Li C; Ren T; Chen S; Ye X; Guo H; He H; Zhang Y; Yin T; Liang XJ; Tang X
    Mol Pharm; 2017 Oct; 14(10):3598-3608. PubMed ID: 28892400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparations of liposomal fluconazole and their in vitro antifungal activity.
    Singh M; Singh MP; Maiti SN; Gandhi A; Micetich RG; Atwal H
    J Microencapsul; 1993; 10(2):229-36. PubMed ID: 8331496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery.
    Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
    Int J Pharm; 2006 Apr; 312(1-2):53-60. PubMed ID: 16469460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between multilamellar and unilamellar liposomes in enhancing antibody formation.
    Shek PN; Yung BY; Stanacev NZ
    Immunology; 1983 May; 49(1):37-44. PubMed ID: 6341213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-fortified liposomes as carriers for sustained release of NSAIDs: The concept and its validation in the animal model for the treatment of arthritis.
    Pawar VA; Manjappa AS; Murumkar PR; Gajaria TK; Devkar RV; Mishra AK; Yadav MR
    Eur J Pharm Sci; 2018 Dec; 125():11-22. PubMed ID: 30219410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of asymmetrical flow field-flow fractionation with on-line detection in the study of drug retention within liposomal nanocarriers and drug transfer kinetics.
    Hinna AH; Hupfeld S; Kuntsche J; Brandl M
    J Pharm Biomed Anal; 2016 May; 124():157-163. PubMed ID: 26950903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study.
    Tseng YL; Liu JJ; Hong RL
    Mol Pharmacol; 2002 Oct; 62(4):864-72. PubMed ID: 12237333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulation of vinorelbine into cholesterol-polyethylene glycol coated vesicles: drug loading and pharmacokinetic studies.
    Li C; Cui J; Wang C; Zhang L; Xiu X; Li Y; Wei N; Li Y; Zhang L
    J Pharm Pharmacol; 2011 Mar; 63(3):376-84. PubMed ID: 21749385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation and physicochemical properties of vinorelbine liposomes].
    Li XT; Cheng L; Jia TZ
    Zhong Yao Cai; 2011 Jan; 34(1):119-22. PubMed ID: 21818978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.